<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=1000083763474443&amp;ev=PageView&amp;noscript=1">

SmartTRAK Life Sciences News and Analysis Blog

Gary Delhougne

SmartTRAK GM, Wound. Licensed attorney with 20 years’ medical device and consulting experience in market access, health economics and policy roles at Smith & Nephew, Covidien, Avalere Health and Ernst & Young.

Recent Posts

2 min read

Continued Growth: Q222 Advanced Wound Care Market Recap

By Gary Delhougne on 9/22/22 9:30 AM

WW Advanced Wound Care continues to grow in the mid-single-digits as company revenues reflect normalcy in wound care with a likely increase in wound severity.

For Q222, SmartTRAK Financial Dashboard reports the WW Advanced Wound Care (AWC) market grew +6.4%. WW Advanced Dressings and WW Wound Biologics were also up, while NPWT-heavy External Devices revenue increased marginally.

Among the many topics covered in detail in our comprehensive Q222 Advanced Wound Care Market Recap* are:

  • Complete Q222 AWC Overview and Highlights
  • SmartTRAK's Expert Analysis and Insights
  • All Company News including Revenues, Data, Charts and Shares
  • Growth Analysis – Currency Having a Significant Impact in Q2
Continue Reading
6 min read

Diagnostic and Digital Devices on Display: WOCNext 2022

By Gary Delhougne on 7/25/22 10:21 AM

Emerging from the COVID-19 era, wound care innovation is driven by small players, especially in the digital and diagnostic spaces

In June, wound, ostomy and continence-focused nurses, and supporting industry gathered in Fort Worth, TX for the hybrid WOCNext 2022 conference. In-person attendance was below expectations, but healthy booth time allowed for product discussions with exhibitors.

SmartTRAK observed that product innovation at WOCNext came from smaller companies and those focused on digital and diagnostic solutions not large manufacturers like Smith+Nephew*, 3M* or Mölnlycke*SmartTRAK learned that the large manufacturers are not launching new products for multiple reasons, including supply chain limitations, access to raw materials and the confidence to be able to supply enough products to serve the market.

SmartTRAK is closely watching advances and innovation in the digital and diagnostic space in wound care. Specifically, SmartTRAK Analyst Kris Flinn recently published an article, "The Future of Biosensors and Smart Dressings in Wound Care Diagnostics", available here, highlighting developments in diagnostic biosensors in smart dressings. Additionally, in an early 2022 interview with reimbursement expert Kathleen Schaum, we learned about reimbursement trends that support the development and use of these products. 

Outlined below are several wound diagnostic and digital products prominently highlighted at WOCN.

Topics: Wound Care
Continue Reading
2 min read

Moving Past COVID: Q122 WW Advanced Wound Care Market Recap

By Gary Delhougne on 6/16/22 9:38 AM

WW Advanced Wound Care growth settles to a traditional mid-single digit growth rate as global wound care moves past COVID-19.

Topics: Wound Care
Continue Reading
3 min read

Leveraging Government Affairs for Commercial Success: An Interview w/ Jack Kalavritinos

By Gary Delhougne on 5/26/22 9:30 AM

Jack Kalavritinos, Former HHS/FDA Senior Official and Principal of JK Strategies, discusses the importance and benefits of government affairs in medtech

Jack Kalavritinos is the Founder and Principal of JK Strategies, a communications and public policy firm that helps organizations develop winning communication and policy strategies. Jack is also a former senior government official and appointee in HHS, FDA and DOL. Jack has decades of Washington, DC government, political and business experience including in the medtech sector with Covidien.

In this interview with SmartTRAK, Jack shares his thoughts on the benefits to medtech commercial leaders of developing collaborative relationships with their government affairs colleagues. Specifically, SmartTRAK’s interview with Jack covers the next phases of the COVID-19 public health emergency, the potential impact of the midterm elections and ways companies can work with the FDA.

To find out more, including Jack’s take on how medtech commercial leaders can develop relationships with their Representatives and Senators, click on the following video recorded live via Zoom. Outlined below are specific interview topics by the minute. To download a complete transcript of the interview, click here.

Continue Reading
5 min read

Trends in Product and IT-Driven Innovations: SAWC Spring 2022

By Gary Delhougne on 5/19/22 10:56 AM

Emerging from the COVID-19 era, wound care innovation is driven by smaller companies

In April, the Symposium on Advanced Wound Care (SAWC) Spring 2022 returned to an in-person format for the first time since 2019. Though the turnout was below expectations, attendees enjoyed reconnecting with clinicians, engaging with vendors and catching up with colleagues and competitors.

Despite being three years since the last SAWC Spring, large wound care companies like Smith+Nephew* (SNN), Mölnlycke*, 3M* and others were oddly without major product introductions. SmartTRAK has learned that extended FDA review timelines and supply challenges may be playing a significant role in this reality. Companies have publicly commented that innovation and new product launches are planned for 2022, but timelines must have slipped past the SAWC Spring deadlines.

Regardless, innovation was not completely absent from SAWC Spring as smaller companies introduced new products and more companies exhibited IT-driven diagnostic, measurement and data-capture technologies.

(The SmartTRAK team will be attending the upcoming European Wound Management Association (EWMA) event May 23-25 in Paris. We would love to schedule some time to meet and hear your perspectives and views and discuss how SmartTRAK can help you make more informed strategic business decisions.)

In this article, SmartTRAK highlights new products and novel technologies exhibited at SAWC Spring 2022.

Topics: Wound Care
Continue Reading
5 min read

Supply Chain and Inflationary Pressures Weigh on Wound Care Companies

By Gary Delhougne on 4/26/22 8:30 AM

Macroeconomic headwinds are projected to continue through the first half of 2022.

Supply chain headaches and inflationary pressures significantly impacted wound care companies in 2021. Though Advanced Wound Care revenue rebounded +11.5% in 2021 according to SmartTRAK’s Financial Dashboard, it was not without strong headwinds of higher input costs, logistical nightmares and labor shortages.

To understand how these macroeconomic trends affected wound care companies, SmartTRAK reviewed quarterly and fiscal year earnings reports from FY21 to see how various wound care companies reported the company-specific impact. From troubles sourcing materials to higher input costs and the need to raise prices, SmartTRAK uncovered a consistent trend of macroeconomic pressures affecting many global and regional wound care manufacturers.

Be The Expert in Wound Care -  Click for FREE SmartTRAK Updates for 30 Days

Topics: Wound Care
Continue Reading
2 min read

Strong Gains with Room to Grow: Q421/FY21 AWC Market Recap

By Gary Delhougne on 4/7/22 9:41 AM

Advanced wound care delivers strong double-digit growth and still has room to grow.

The WW Advanced Wound Care markets regained their form in FY21 as wound care recovered globally after COVID-19 impacted FY20. Advanced Dressings delivered nearly double-digit growth, with Wound Biologics and External Devices also reporting excellent revenue growth vs FY20.

Among the many topics covered in detail in our comprehensive Q421/FY21 AWC Market Recap* are:

Continue Reading
2 min read

The Future is Today in Remote Patient Monitoring: An Interview with Scott Laster

By Gary Delhougne on 3/28/22 9:30 AM

Scott Laster, CEO and co-founder of MiCare Path, discusses the present and future of monitoring patients between office visits in an interview with SmartTRAK

Scott Laster is the CEO and co-founder of MiCare Path, a leading platform to connect patients with their providers between visits. Scott is a medical device industry veteran with 15+ years of experience in the trenches launching products and supporting clinicians. In this interview with SmartTRAK, Scott shares his thoughts on the benefits of monitoring patients between office visits, the evolution of reimbursement of remote monitoring and where MiCare Path is going in the future.

To find out more, including Scott’s take on how MiCare Path benefits orthopedic and wound care patients and clinicians, click on the following video recorded live via Google Meet (17:04 min). Specific interview topics by timecode are outlined below. To download a complete transcript of the interview, click here.

Continue Reading
2 min read

What's New in Wound Care Reimbursement 2022: An Interview w/ Kathleen Schaum

By Gary Delhougne on 3/4/22 11:36 AM

Kathleen “Kathy” Schaum, President of Kathleen D. Schaum & Associates, discusses her thoughts on the impact of COVID-19 on wound care and reimbursement.

Kathy is a “go-to” provider of wound care reimbursement information, education and strategy to manufacturers and providers. In this interview with SmartTRAK, Kathy shares her thoughts on the impact of COVID-19 on the delivery and reimbursement of wound care and the advancements in remote monitoring, diagnostics and sensors. To find out more, including Kathy’s take on skin substitute/CTP trends, click on the following video recorded live via Google Meet (25:13 min). Specific interview topics by time code are outlined below. A link to the complete transcript of the interview is also provided below.

Continue Reading
5 min read

SmartTRAK’s 2022 Outlook for the US Skin Substitute/CTP Market

By Gary Delhougne on 2/8/22 9:30 AM

From Site of Care Migration to the Impact of Reimbursement Changes SmartTRAK evaluates market trends to watch for in 2022.
by Gary Delhougne, GM Wound

The Skin Substitute/CTP (Cellular and/or Tissue-based Products) market is undergoing significant growth and change. Reimbursement motives, COVID-19 and clinician site of care decisions had a profound impact on the market in 2020 and 2021. The growth outlook for 2022 remains strong as providers and industry adapt to unique market conditions.

SmartTRAK estimates the 5-year CAGR (compound annual growth rate) through 2025 for Skin Substitutes/CTP products to be in the mid to high single digits. In 2020, industry revenue surpassed $1B and SmartTRAK expects the market to pass $1.5B by 2025.

To better understand the impact of site of care changes, SmartTRAK launched a new subscription module specifically covering site of care changes occurring in the Skin Substitute/CTP market. It’s SmartTRAK’s fastest-growing new product offering and you can learn more by clicking here.

As SmartTRAK looks to 2022, we see three trends to consider for the Skin Substitute/CTP market –

Continue Reading

    Follow Us on Social Media

    Recent Articles